36 related articles for article (PubMed ID: 3309933)
21. The clinical utility of C-peptide measurement in the care of patients with diabetes.
Jones AG; Hattersley AT
Diabet Med; 2013 Jul; 30(7):803-17. PubMed ID: 23413806
[TBL] [Abstract][Full Text] [Related]
22. [Pathogenesis and therapy of type I and type II diabetes mellitus].
Prager R
Wien Med Wochenschr; 1988 Jul; 138(14):337-40. PubMed ID: 3062911
[TBL] [Abstract][Full Text] [Related]
23. C-peptide and residual β-cell function in pediatric diabetes - state of the art.
Jamiołkowska-Sztabkowska M; Głowińska-Olszewska B; Bossowski A
Pediatr Endocrinol Diabetes Metab; 2021; 27(2):123-133. PubMed ID: 34514768
[TBL] [Abstract][Full Text] [Related]
24. [C-peptide in blood].
Matsuda A
Nihon Rinsho; 2002 Aug; 60 Suppl 8():378-83. PubMed ID: 12355776
[No Abstract] [Full Text] [Related]
25. Challenges in developing endpoints for type 1 diabetes intervention studies.
Cernea S; Raz I; Herold KC; Hirshberg B; Roep BO; Schatz DA; Fleming GA; Pozzilli P; Little R; Schloot NC; Leslie RD; Skyler JS; Palmer JP;
Diabetes Metab Res Rev; 2009 Nov; 25(8):694-704. PubMed ID: 19771545
[TBL] [Abstract][Full Text] [Related]
26. [C-peptide, new discoveries and therapeutic implications].
Wahren J; Johansson BL; Ekberg K
Journ Annu Diabetol Hotel Dieu; 1999; ():231-41. PubMed ID: 10732420
[No Abstract] [Full Text] [Related]
27. C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.
Maddaloni E; Bolli GB; Frier BM; Little RR; Leslie RD; Pozzilli P; Buzzetti R
Diabetes Obes Metab; 2022 Oct; 24(10):1912-1926. PubMed ID: 35676794
[TBL] [Abstract][Full Text] [Related]
28. [Effect of hyperbaric oxygenation on residual insulin secretion in patients with diabetes mellitus type 1].
Dedov II; Lukich VL; Bol'shakova TD; Gitel' EP; Dreval' AV
Probl Endokrinol (Mosk); 1987; 33(4):10-5. PubMed ID: 3309933
[TBL] [Abstract][Full Text] [Related]
29. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
[TBL] [Abstract][Full Text] [Related]
30. [C-peptide residual secretion makes difference on type 1 diabetes management?].
Rodacki M; Milech A; Oliveira JE
Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):322-33. PubMed ID: 18438543
[TBL] [Abstract][Full Text] [Related]
31. [The natural history of diabetes with respect to disorders of insulin function].
Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
[No Abstract] [Full Text] [Related]
32. Treatment of type 1 diabetes mellitus to preserve insulin secretion.
Herold KC
Endocrinol Metab Clin North Am; 2004 Mar; 33(1):93-111, ix. PubMed ID: 15053897
[No Abstract] [Full Text] [Related]
33. The rise and fall of insulin secretion in type 1 diabetes mellitus.
Tsai EB; Sherry NA; Palmer JP; Herold KC
Diabetologia; 2006 Feb; 49(2):261-70. PubMed ID: 16404554
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
